ecabet has been researched along with ranitidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Kume, E; Nagasaki, M; Noto, T; Okuyama, K; Saito, N | 1 |
1 review(s) available for ecabet and ranitidine
| Article | Year |
|---|---|
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
1 other study(ies) available for ecabet and ranitidine
| Article | Year |
|---|---|
Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Topics: Abietanes; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Esophageal Diseases; Esophagus; Gastric Juice; Gastroesophageal Reflux; Male; Mucous Membrane; Omeprazole; Pepsin A; Ranitidine; Rats; Rats, Sprague-Dawley | 2007 |